Role of microRNA-335 in chronic liver diseases
DOI:10.3969/j.issn.1001-5256.2021.02.047
- VernacularTitle:microRNA-335在慢性肝病中的作用
- Author:
Yajie YUAN
1
;
Haojie DING
;
Qingming KONG
Author Information
1. Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou 310000, China
- Publication Type:Research Article
- Keywords:
Hepatitis;
Liver Cirrhosis;
Carcinoma, Hepatocellular;
MicroRNAs
- From:
Journal of Clinical Hepatology
2021;37(2):471-474
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the regulatory role of microRNAs in liver pathological process has attracted more and more attention. In viral hepatitis and steatohepatitis, microRNA-335 (miRNA-335) regulates the progression of hepatitis via the transcription factor sex-determining region Y-box 4; in the development and progression of progressive liver fibrosis and liver cancer, miRNA-335 affects collagen production, deposition, and degradation in the liver via the target genes including hypoxia-inducible factor 1α, phosphatase and tensin homologue, Rho-associated coiled-coil containing protein kinase 1, plasminogen activator inhibitor-1, twist family bHLH transcription factor 1, and mesenchymal-epithelial transition factor and thus regulates the migration and invasion of hepatic stellate cells and hepatoma cells. This article summarizes the research advances in the role of miRNA-335 in hepatitis, liver fibrosis, and liver cancer in recent years, and based on existing data, it is pointed out that the miRNA-335/QSOX1 regulatory axis may mediate artesunate against schistosomal liver fibrosis by inhibiting hepatic stellate cell activation, so as to provide new ideas for the treatment of liver fibrosis and other liver diseases.
